Uterine Cancer Diagnostic Testing Market Size, Share, Growth, and Regional Forecast, 2025 to 2033

Table of Content

1. Executive Summary
   1. Global Uterine Cancer Diagnostic Testing Market Snapshot, 2026 and 2033
   2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. COVID-19 Impact Analysis
   4. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Value Chain Analysis
   2. Diseases Epidemiology
   3. Test Adoption / Usage Analysis
   4. Key Market Players
   5. Key Promotional Strategies, By Key Players
   6. Regulatory Landscape
   7. PESTLE Analysis
   8. Porter’s Five Force Analysis
4. Global Uterine Cancer Diagnostic Testing Market Outlook
   1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2033
   3. Global Uterine Cancer Diagnostic Testing Market Outlook: Cancer Type
      1. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2020-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
         1. Endometrial Carcinoma
         2. Uterine Sarcoma
      3. Market Attractiveness Analysis: Cancer Type
   4. Global Uterine Cancer Diagnostic Testing Market Outlook: Diagnostic Test
      1. Historical Market Size (US$ Bn) Analysis, By Diagnostic Test, 2020-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
         1. Ultrasound Scanning
            1. Abdominal Ultrasound Scanning
            2. Transvaginal Ultrasound Scanning
         2. Biopsy Procedures
            1. Endometrial Biopsy
            2. Hysteroscopy
            3. Dilation & Curettage
         3. Blood Tests
            1. Complete Blood Count
            2. CA125 Marker Blood Test
      3. Market Attractiveness Analysis: Diagnostic Test
   5. Global Uterine Cancer Diagnostic Testing Market Outlook: End User
      1. Historical Market Size (US$ Bn) Analysis, By End User, 2020-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
         1. Hospitals
         2. Ambulatory Surgical Centers
         3. Cancer Research Institutes
         4. Specialized Clinics
         5. Diagnostic Laboratories
         6. Others
      3. Market Attractiveness Analysis: End User
5. Global Uterine Cancer Diagnostic Testing Market Outlook: Region
   1. Historical Market Size (US$ Bn) Analysis, By Region, 2020-2024
   2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2033
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
   3. Market Attractiveness Analysis: Region
6. North America Uterine Cancer Diagnostic Testing Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
      1. By Country
      2. By Cancer Type
      3. By Diagnostic Test
      4. By End User
   2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
      1. U.S.
      2. Canada
   3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
      1. Endometrial Carcinoma
      2. Uterine Sarcoma
   4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
      1. Ultrasound Scanning
         1. Abdominal Ultrasound Scanning
         2. Transvaginal Ultrasound Scanning
      2. Biopsy Procedures
         1. Endometrial Biopsy
         2. Hysteroscopy
         3. Dilation & Curettage
      3. Blood Tests
         1. Complete Blood Count
         2. CA125 Marker Blood Test
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Research Institutes
      4. Specialized Clinics
      5. Diagnostic Laboratories
      6. Others
   6. Market Attractiveness Analysis
7. Europe Uterine Cancer Diagnostic Testing Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
      1. By Country
      2. By Cancer Type
      3. By Diagnostic Test
      4. By End User
   2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
      1. Endometrial Carcinoma
      2. Uterine Sarcoma
   4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
      1. Ultrasound Scanning
         1. Abdominal Ultrasound Scanning
         2. Transvaginal Ultrasound Scanning
      2. Biopsy Procedures
         1. Endometrial Biopsy
         2. Hysteroscopy
         3. Dilation & Curettage
      3. Blood Tests
         1. Complete Blood Count
         2. CA125 Marker Blood Test
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Research Institutes
      4. Specialized Clinics
      5. Diagnostic Laboratories
      6. Others
   6. Market Attractiveness Analysis
8. East Asia Uterine Cancer Diagnostic Testing Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
      1. By Country
      2. By Cancer Type
      3. By Diagnostic Test
      4. By End User
   2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
      1. China
      2. Japan
      3. South Korea
   3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
      1. Endometrial Carcinoma
      2. Uterine Sarcoma
   4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
      1. Ultrasound Scanning
         1. Abdominal Ultrasound Scanning
         2. Transvaginal Ultrasound Scanning
      2. Biopsy Procedures
         1. Endometrial Biopsy
         2. Hysteroscopy
         3. Dilation & Curettage
      3. Blood Tests
         1. Complete Blood Count
         2. CA125 Marker Blood Test
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Research Institutes
      4. Specialized Clinics
      5. Diagnostic Laboratories
      6. Others
   6. Market Attractiveness Analysis
9. South Asia & Oceania Uterine Cancer Diagnostic Testing Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
      1. By Country
      2. By Cancer Type
      3. By Diagnostic Test
      4. By End User
   2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
   3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
      1. Endometrial Carcinoma
      2. Uterine Sarcoma
   4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
      1. Ultrasound Scanning
         1. Abdominal Ultrasound Scanning
         2. Transvaginal Ultrasound Scanning
      2. Biopsy Procedures
         1. Endometrial Biopsy
         2. Hysteroscopy
         3. Dilation & Curettage
      3. Blood Tests
         1. Complete Blood Count
         2. CA125 Marker Blood Test
   5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cancer Research Institutes
      4. Specialized Clinics
      5. Diagnostic Laboratories
      6. Others
   6. Market Attractiveness Analysis
10. Latin America Uterine Cancer Diagnostic Testing Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
       1. By Country
       2. By Cancer Type
       3. By Diagnostic Test
       4. By End User
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
       1. Endometrial Carcinoma
       2. Uterine Sarcoma
    4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
       1. Ultrasound Scanning
          1. Abdominal Ultrasound Scanning
          2. Transvaginal Ultrasound Scanning
       2. Biopsy Procedures
          1. Endometrial Biopsy
          2. Hysteroscopy
          3. Dilation & Curettage
       3. Blood Tests
          1. Complete Blood Count
          2. CA125 Marker Blood Test
    5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
       1. Hospitals
       2. Ambulatory Surgical Centers
       3. Cancer Research Institutes
       4. Specialized Clinics
       5. Diagnostic Laboratories
       6. Others
    6. Market Attractiveness Analysis
11. Middle East & Africa Uterine Cancer Diagnostic Testing Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2024
       1. By Country
       2. By Cancer Type
       3. By Diagnostic Test
       4. By End User
    2. Market Size (US$ Bn) Analysis and Forecast by Country, 2025-2033
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2025-2033
       1. Endometrial Carcinoma
       2. Uterine Sarcoma
    4. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2033
       1. Ultrasound Scanning
          1. Abdominal Ultrasound Scanning
          2. Transvaginal Ultrasound Scanning
       2. Biopsy Procedures
          1. Endometrial Biopsy
          2. Hysteroscopy
          3. Dilation & Curettage
       3. Blood Tests
          1. Complete Blood Count
          2. CA125 Marker Blood Test
    5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2033
       1. Hospitals
       2. Ambulatory Surgical Centers
       3. Cancer Research Institutes
       4. Specialized Clinics
       5. Diagnostic Laboratories
       6. Others
    6. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping by Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Abbott Laboratories
          1. Overview
          2. Segments and Distribution Channels
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Roche Holdings AG
       3. Siemens AG
       4. Danaher
       5. BioMerieux SA
       6. Sanofi
       7. Becton, Dickinson & Co.
       8. GlaxoSmithKline Plc
       9. Merck & Co., Inc.
       10. Novartis AG
       11. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations